Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New tool could help surgeons pick the right antibiotic for allergy patients

NCT ID NCT07342647

First seen Jan 18, 2026 · Last updated Jun 22, 2026 · Updated 20 times

Summary

This study aims to improve how doctors choose antibiotics for patients who say they are allergic to penicillin-like drugs (beta-lactams) before orthopedic surgery. Many people think they are allergic, but only a small fraction truly are. Researchers will use a simple questionnaire called the PEN FAST score to guide antibiotic choices. The goal is to see if this tool increases the number of correct prescriptions and reduces errors.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BETA LACTAM ADVERSE REACTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Service de Pharmacie - Stérilisation - CHU de Strasbourg - France

    RECRUITING

    Strasbourg, 67091, France

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

PEN FAST score (a questionnaire-based risk assessment tool)

What this could lead to

If successful, this could help doctors prescribe safer, more effective antibiotics for patients with reported penicillin allergies, reducing infection risks.

What could go wrong

This is a small, single-center study with only 50 participants, so results may not apply broadly. The scoring tool may not catch all true allergies.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.